Yanan Zhang

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 11

Top Topics

Structure Activity Relationship

Cerebral Ischemia

Alcohol Use Disorder

Top Venues

Journal of medicinal chemistry

ACS chemical neuroscience

Pharmaceuticals (Basel, Switzerland)

The Journal of pharmacology and experimental therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Dehui Zhang, David A Perrey, Ann M Decker, Tiffany L Langston, Vijayakumar Mavanji, Danni L Harris, Catherine M Kotz, Yanan Zhang
Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists. Journal of medicinal chemistry 64 (12) (2021)
Dennis F Lovelock, Thuy Nguyen, Kalynn Van Voorhies, Yanan Zhang, Joyce Besheer
RTICBM-74 Is a Brain-Penetrant Cannabinoid Receptor Subtype 1 Allosteric Modulator that Reduces Alcohol Intake in Rats. The Journal of pharmacology and experimental therapeutics 380 (3) (2021)
Allison Zarkin, Rajwana Jahan, Rajendra Uprety, Yanan Zhang, Charles McElhinny, Rodney Snyder, Elaine Gay, Gabriel Jewula, Heather Bool, Stewart D Clark, Scott Runyon
Identification of a Novel Neuropeptide S Receptor Antagonist Scaffold Based on the SHA-68 Core. Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Thuy Nguyen, Thomas F Gamage, David B Finlay, Ann M Decker, Tiffany L Langston, Daniel Barrus, Michelle Glass, Jun-Xu Li, Terry P Kenakin, Yanan Zhang
Development of 3-(4-Chlorophenyl)-1-(phenethyl)urea Analogues as Allosteric Modulators of the Cannabinoid Type-1 Receptor: RTICBM-189 is Brain Penetrant and Attenuates Reinstatement of Cocaine-Seeking Behavior. Journal of medicinal chemistry 65 (1) (2021)
Thuy Nguyen, Julie Marusich, Jun-Xu Li, Yanan Zhang
Neuropeptide FF and Its Receptors: Therapeutic Applications and Ligand Development. Journal of medicinal chemistry 63 (21) (2020)
Thuy Nguyen, Thomas F Gamage, Ann M Decker, Daniel Barrus, Tiffany L Langston, Jun-Xu Li, Brian F Thomas, Yanan Zhang
Synthesis and Pharmacological Evaluation of 1-Phenyl-3-Thiophenylurea Derivatives as Cannabinoid Type-1 Receptor Allosteric Modulators. Journal of medicinal chemistry 62 (21) (2019)
Thuy Nguyen, Thomas F Gamage, Ann M Decker, Nadezhda German, Tiffany L Langston, Charlotte E Farquhar, Terry P Kenakin, Jenny L Wiley, Brian F Thomas, Yanan Zhang
Diarylureas Containing 5-Membered Heterocycles as CB1 Receptor Allosteric Modulators: Design, Synthesis, and Pharmacological Evaluation. ACS chemical neuroscience 10 (1) (2018)
George S Amato, Amruta Manke, Danni L Harris, Robert W Wiethe, Vineetha Vasukuttan, Rodney W Snyder, Timothy W Lefever, Ricardo Cortes, Yanan Zhang, Shaobin Wang, Scott P Runyon, Rangan Maitra
Blocking Alcoholic Steatosis in Mice with a Peripherally Restricted Purine Antagonist of the Type 1 Cannabinoid Receptor. Journal of medicinal chemistry 61 (10) (2018)
David A Perrey, Ann M Decker, Yanan Zhang
Synthesis and Evaluation of Orexin-1 Receptor Antagonists with Improved Solubility and CNS Permeability. ACS chemical neuroscience 9 (3) (2017)
Thuy Nguyen, Nadezhda German, Ann M Decker, Tiffany L Langston, Thomas F Gamage, Charlotte E Farquhar, Jun-Xu Li, Jenny L Wiley, Brian F Thomas, Yanan Zhang
Novel Diarylurea Based Allosteric Modulators of the Cannabinoid CB1 Receptor: Evaluation of Importance of 6-Pyrrolidinylpyridinyl Substitution. Journal of medicinal chemistry 60 (17) (2017)
Thuy Nguyen, Ann M Decker, Tiffany L Langston, Kelly M Mathews, Justin N Siemian, Jun-Xu Li, Danni L Harris, Scott P Runyon, Yanan Zhang
Discovery of Novel Proline-Based Neuropeptide FF Receptor Antagonists. ACS chemical neuroscience 8 (10) (2017)